182 related articles for article (PubMed ID: 8998176)
1. Bisphosphonates spearhead new approach to treating bone metastases.
Bankhead C
J Natl Cancer Inst; 1997 Jan; 89(2):115-6. PubMed ID: 8998176
[No Abstract] [Full Text] [Related]
2. Bisphosphonates may be useful in treatment of bone metastases.
Jones J
J Natl Cancer Inst; 2001 Jul; 93(14):1052-3. PubMed ID: 11459865
[No Abstract] [Full Text] [Related]
3. Bisphosphonate treatment of bone metastases and hypercalcemia of malignancy.
Coleman RE
Oncology (Williston Park); 1991 Aug; 5(8):55-60; discussion 60-2, 65. PubMed ID: 1834153
[TBL] [Abstract][Full Text] [Related]
4. Use of bisphosphonates in cancer patients.
Body JJ; Coleman RE; Piccart M
Cancer Treat Rev; 1996 Jul; 22(4):265-87. PubMed ID: 9025784
[No Abstract] [Full Text] [Related]
5. [Is pamidronate or clodronate better?].
Adam Z
Vnitr Lek; 2002 Apr; 48(4):357. PubMed ID: 12075601
[No Abstract] [Full Text] [Related]
6. Bisphosphonates as anticancer drugs.
Mundy GR; Yoneda T
N Engl J Med; 1998 Aug; 339(6):398-400. PubMed ID: 9691109
[No Abstract] [Full Text] [Related]
7. [Bisphosphonates in the treatment of breast carcinoma].
Stajszczyk M; Mykała-Cieśla J
Pol Arch Med Wewn; 2001 Aug; 106(2):729-38. PubMed ID: 11926150
[No Abstract] [Full Text] [Related]
8. [Zoledronic acid and bone pathology in the course of neoplasia. Part I].
Caffo O
Tumori; 2005; 91(5):22-6. PubMed ID: 16459649
[No Abstract] [Full Text] [Related]
9. Prevention of bone metastases and management of bone health in early breast cancer.
Gnant M; Hadji P
Breast Cancer Res; 2010; 12(6):216. PubMed ID: 21172067
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates in the prevention of bone metastases: current evidence.
Diel IJ
Semin Oncol; 2001 Aug; 28(4 Suppl 11):75-80. PubMed ID: 11544581
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate therapy in metastatic breast cancer.
Blomqvist C; Elomaa I
Acta Oncol; 1996; 35 Suppl 5():81-3. PubMed ID: 9142974
[TBL] [Abstract][Full Text] [Related]
12. Aredia: the once-monthly infusion for the treatment of bone metastases.
Lipton A
Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S1-5. PubMed ID: 9801852
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy.
Clemons MJ; Dranitsaris G; Ooi WS; Yogendran G; Sukovic T; Wong BY; Verma S; Pritchard KI; Trudeau M; Cole DE
J Clin Oncol; 2006 Oct; 24(30):4895-900. PubMed ID: 17001071
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonates: lingering questions about their use.
Derrane M
J Natl Cancer Inst; 1998 Sep; 90(18):1329-31. PubMed ID: 9747862
[No Abstract] [Full Text] [Related]
15. Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer.
Paterson AH; Kanis JA; Powles TJ; McCloskey E; Hanson J; Ashley S
Can J Oncol; 1995 Dec; 5 Suppl 1():54-7. PubMed ID: 8853526
[TBL] [Abstract][Full Text] [Related]
16. [Bisphosphonates and bone metastases].
Lortholary A; Jadaud E; Berthaud P
Bull Cancer; 1999 Sep; 86(9):732-8. PubMed ID: 10519966
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonates in the treatment of skeletal metastases.
Conte P; Coleman R
Semin Oncol; 2004 Oct; 31(5 Suppl 10):59-63. PubMed ID: 15490377
[TBL] [Abstract][Full Text] [Related]
18. [Osteolytic metastases of breast cancer and biphosphonates].
Lortholary A; Alleaume C; Pein F; Larra F
Rev Med Interne; 1992; 13(3):238-42. PubMed ID: 1410908
[TBL] [Abstract][Full Text] [Related]
19. Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
Body JJ; Bartl R; Burckhardt P; Delmas PD; Diel IJ; Fleisch H; Kanis JA; Kyle RA; Mundy GR; Paterson AH; Rubens RD
J Clin Oncol; 1998 Dec; 16(12):3890-9. PubMed ID: 9850035
[TBL] [Abstract][Full Text] [Related]
20. Bone metastases and breast cancer.
Coleman RE; Rubens RD
Cancer Treat Rev; 1985 Dec; 12(4):251-70. PubMed ID: 2938732
[No Abstract] [Full Text] [Related]
[Next] [New Search]
